NBC10 Boston on Mythryl: “An experimental pancreatic cancer drug that’s been shown to double…”

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say. on.nbcboston.com/Jhz6ABy

on.nbcboston.com'A watershed moment': A pancreatic cancer drug is set to transform treatmentPatients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one appears to be within reach.

7/5/26, 2:00 am3 reposts5 likes

Post